Alex Carballo-Diéguez

Alex Carballo-Diéguez

Auto-generated profile, based on publicly available information

Alex Carballo-Diéguez

HIV Center for Clinical and Behavioral Studies, Division of Gender, Sexuality and Health, NY State Psychiatric Institute and Columbia University, New York, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2015 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
RSRebecca Schnall
Rebecca Schnall
JMJocelyn Patterson Mosley
Jocelyn Patterson Mosley
SISarah J Iribarren
Sarah J Iribarren
SBSuzanne Bakken
Suzanne Bakken
ACAlex Carballo-Diéguez
Alex Carballo-Diéguez
WIWilliam Brown Iii
William Brown Iii
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

13 May 2016 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
SISarah J Iribarren
Sarah J Iribarren
RSRebecca Schnall
Rebecca Schnall
PSPatricia W Stone
Patricia W Stone
ACAlex Carballo-Diéguez
Alex Carballo-Diéguez
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

27 July 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
CRChristine Tagliaferri Rael
Christine Tagliaferri Rael
CLCody Lentz
Cody Lentz
ACAlex Carballo-Diéguez
Alex Carballo-Diéguez
RGRebecca Giguere
Rebecca Giguere
CDCurtis Dolezal
Curtis Dolezal
THThomas Hope
Thomas Hope
Background: A long-acting implant for HIV pre-exposure prophylaxis (PrEP) is in development in the Sustained Long-Action Prevention Against HIV (SLAP-HIV) trial. This could provide an alternative to oral PrEP. Objective: Our mixed methods study aimed to understand (1) users’ experiences with a similar subdermal implant for contraception and (2) factors influencing the likelihood that gay and bisexual men (GBM) would use a proposed PrEP implant. Methods: Work was completed in 4 stages. In stage 1, we conducted a scientific literature review on existing subdermal implants, focusing on users’ experiences with implant devices. In stage 2, we reviewed videos on YouTube, focusing on the experiences of current or former contraceptive implant users (as these implants are similar to those in development in SLAP-HIV). In stage 3, individuals who indicated use of a subdermal implant for contraception in the last 5 years were recruited via a web-based questionnaire. Eligible participants (n=12 individuals who liked implants a lot and n=12 individuals who disliked implants a lot) completed in-depth phone interviews (IDIs) about their experiences. In stage 4, results from IDIs were used to develop a web-based survey for HIV-negative GBM to rate their likelihood of using a PrEP implant on a scale (1=very unlikely and 5=very likely) based on likely device characteristics and implant concerns identified in the IDIs. Results: In the scientific literature review (stage 1), concerns about contraceptive implants that could apply to the PrEP implants in development included potential side effects (eg, headache), anticipated high cost of the device, misconceptions about PrEP implants (eg, specific contraindications), and difficulty accessing PrEP implants. In the stage 2 YouTube review, individuals who had used contraceptive implants reported mild side effects related to their device. In stage 3, implant users reported that devices were comfortable, unintrusive, and presented only minor discomfort (eg, bruising) before or after insertion and removal. They mainly reported removing or disliking the device due to contraceptive-related side effects (eg, prolonged menstruation). Participants in the stage 4 quantitative survey (N=304) were mainly gay (204/238, 85.7%), white (125/238, 52.5%), cisgender men (231/238, 97.1%), and 42.0% (73/174) of them were on oral PrEP. Not having to take a daily pill increased the likelihood of using PrEP implants (mean 4.13). Requiring >1 device to achieve 1 year of protection (mean range 1.79-2.94) mildly discouraged PrEP implant use. Participants did not mind moderate bruising, a small scar, tenderness, or bleeding after insertion or removal, and an implant with a size slightly larger than a matchstick (mean ratings 3.18-3.69). Conclusions: PrEP implants are promising among GBM. Implant features and insertion or removal-related concerns do not seem to discourage potential users. To ensure acceptability, PrEP implants should require the fewest possible implants for the greatest protection duration.

24 August 2017 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
RGRebecca Giguere
Rebecca Giguere
WIWilliam Brown Iii
William Brown Iii
IBIvan C Balán
Ivan C Balán
CDCurtis Dolezal
Curtis Dolezal
THTitcha Ho
Titcha Ho
ACAlex Carballo-Diéguez
Alex Carballo-Diéguez
Objective: During a Phase 2 rectal microbicide trial, men who have sex with men and transgender women (n = 187) in 4 countries (Peru, South Africa, Thailand, United States) reported product use daily via short message service (SMS). To prevent disclosure of study participation, the SMS system program included privacy and security features. We evaluated participants’ perceptions of privacy while using the system and acceptability of privacy/security features.Materials and Methods: To protect privacy, the SMS system: (1) confirmed participant availability before sending the study questions, (2) required a password, and (3) did not reveal product name or study participation. To ensure security, the system reminded participants to lock phone/delete messages. A computer-assisted self-interview (CASI), administered at the final visit, measured burden of privacy and security features and SMS privacy concerns. A subsample of 33 participants underwent an in-depth interview (IDI).Results: Based on CASI, 85% had no privacy concerns; only 5% were very concerned. Most were not bothered by the need for a password (73%) or instructions to delete messages (82%). Based on IDI, reasons for low privacy concerns included sending SMS in private or feeling that texting would not draw attention. A few IDI participants found the password unnecessary and more than half did not delete messages.Discussion: Most participants were not concerned that the SMS system would compromise their confidentiality. SMS privacy and security features were effective and not burdensome.Conclusion: Short ID-related passwords, ambiguous language, and reminders to implement privacy and security-enhancing behaviors are recommended for SMS systems.

9 June 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JBJose Bauermeister
Jose Bauermeister
RGRebecca Giguere
Rebecca Giguere
CLCheng-Shiun Leu
Cheng-Shiun Leu
IFIrma Febo
Irma Febo
RCRoss Cranston
Ross Cranston
ACAlex Carballo-Diéguez
Alex Carballo-Diéguez
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

4 June 2015 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
WIWilliam Brown Iii
William Brown Iii
MIMobolaji Ibitoye
Mobolaji Ibitoye
SBSuzanne Bakken
Suzanne Bakken
RSRebecca Schnall
Rebecca Schnall
IBIván Balán
Iván Balán
ACAlex Carballo-Diéguez
Alex Carballo-Diéguez
Background: Most mHealth tools such as short message service (SMS), mobile apps, wireless pill counters, and ingestible wireless monitors use mobile antennas to communicate. Limited signal availability, often due to poor antenna infrastructure, negatively impacts the implementation of mHealth tools and remote data collection. Assessing the antenna infrastructure prior to starting a study can help mitigate this problem. Currently, there are no studies that detail whether and how the antenna infrastructure of a study site or area is assessed. Objective: To address this literature gap, we analyze and discuss the use of a cartographic analysis of antennas and towers (CAAT) for mobile communications for geographically assessing mobile antenna and tower infrastructure and identifying signal availability for mobile devices prior to the implementation of an SMS-based mHealth pilot study. Methods: An alpha test of the SMS system was performed using 11 site staff. A CAAT for the study area’s mobile network was performed after the alpha test and pre-implementation of the pilot study. The pilot study used a convenience sample of 11 high-risk men who have sex with men who were given human immunodeficiency virus test kits for testing nonmonogamous sexual partners before intercourse. Product use and sexual behavior were tracked through SMS. Message frequency analyses were performed on the SMS text messages, and SMS sent/received frequencies of 11 staff and 11 pilot study participants were compared. Results: The CAAT helped us to successfully identify strengths and weaknesses in mobile service capacity within a 3-mile radius from the epicenters of four New York City boroughs. During the alpha test, before CAAT, 1176/1202 (97.84%) text messages were sent to staff, of which 26/1176 (2.21%) failed. After the CAAT, 2934 messages were sent to pilot study participants and none failed. Conclusions: The CAAT effectively illustrated the research area’s mobile infrastructure and signal availability, which allowed us to improve study setup and sent message success rates. The SMS messages were sent and received with a lower fail rate than those reported in previous studies. [JMIR mHealth uHealth 2015;3(2):e63]